2,4-thiazolidinedione has been researched along with Age-Related Osteoporosis in 6 studies
thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, BR | 1 |
| Cha, SH | 1 |
| Lee, KE | 1 |
| Kim, JW | 1 |
| Lee, J | 1 |
| Shin, KH | 1 |
| Okazaki, R | 1 |
| Fukunaga, T | 1 |
| Zou, W | 1 |
| Rohatgi, N | 1 |
| Colca, JR | 1 |
| Teitelbaum, SL | 1 |
| Mori, S | 1 |
| Schwartz, AV | 1 |
| Sellmeyer, DE | 1 |
| Vittinghoff, E | 1 |
| Palermo, L | 1 |
| Lecka-Czernik, B | 1 |
| Feingold, KR | 1 |
| Strotmeyer, ES | 1 |
| Resnick, HE | 1 |
| Carbone, L | 1 |
| Beamer, BA | 1 |
| Park, SW | 1 |
| Lane, NE | 1 |
| Harris, TB | 1 |
| Cummings, SR | 1 |
| Yaturu, S | 1 |
3 reviews available for 2,4-thiazolidinedione and Age-Related Osteoporosis
| Article | Year |
|---|---|
[Fracture risk associated with drugs other than glucocorticoids].
Topics: Adrenergic beta-Antagonists; Androgen Antagonists; Anticonvulsants; Aromatase Inhibitors; Fractures, | 2014 |
[Pharmacotherapy of osteoporosis accompanied by lifestyle-related diseases].
Topics: Adrenergic beta-Antagonists; Animals; Cardiovascular Diseases; Diabetes Complications; Diphosphonate | 2011 |
Diabetes and skeletal health.
Topics: Adipocytes; Animals; Bone and Bones; Bone Density; Diabetes Complications; Diabetes Mellitus; Diabet | 2009 |
3 other studies available for 2,4-thiazolidinedione and Age-Related Osteoporosis
| Article | Year |
|---|---|
Effect of dipeptidyl peptidase IV inhibitors, thiazolidinedione, and sulfonylurea on osteoporosis in patients with type 2 diabetes: population-based cohort study.
Topics: Cohort Studies; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Humans; Osteoporosis; | 2021 |
An insulin-sensitizing thiazolidinedione, which minimally activates PPARĪ³, does not cause bone loss.
Topics: Animals; Insulin; Male; Mice; Mice, Inbred C57BL; Osteoclasts; Osteoporosis; PPAR gamma; Thiazolidin | 2015 |
Thiazolidinedione use and bone loss in older diabetic adults.
Topics: Absorptiometry, Photon; Aged; Blood Glucose; Body Weight; Bone Density; Cohort Studies; Diabetes Mel | 2006 |